Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Remedy: Control Resonant surpasses one million sold copies milestone

REMEDYAnalyst Comment16.10.2026 klo 08.55
Atte RiikolaAnalyst
Discuss

Summary

  • Remedy's game Control Resonant, released on September 24, has sold over one million copies, marking it as the fastest-selling game in the company's 31-year history.
  • The game achieved this milestone within approximately three weeks, despite launching in a highly competitive market, and is Remedy's first large-scale self-publishing project, allowing the company to retain a larger share of sales revenue.
  • The analyst maintains a full-year 2026 sales estimate of 1.9 million copies but acknowledges that Q3 sales expectations were overly optimistic due to delayed availability of physical copies, shifting sales to the last quarter.
  • Reaching the one-million-copy milestone is seen as a significant step for the Control brand's long-term potential and Remedy's transition to self-publishing.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 10/16/2026 at 7:50 am EEST.

Remedy announced on Thursday that the company's game Control Resonant, released on September 24, has surpassed the milestone of one million copies sold. The achievement confirms that the game is on track for commercial success. Preliminary signs of this have already been seen in the post-launch Steam data and excellent reviews from both critics and players.
In light of the press release, our full-year 2026 sales assumption for the game (1.9 million copies) is, in our view, still in the right ballpark.

Fastest selling game in Remedy's history

Global sales of the game surpassed the one-million-copy milestone in around 3 weeks from its release, making it the fastest-selling game in Remedy's 31-year history. Remedy emphasizes in its press release that breaking the million mark is "a very strong start," considering that the game was released alongside some of the biggest names in the industry into one of the most competitive launch windows in years. Since this is Remedy's first large-scale self-publishing project, the company will also receive a significantly larger share of the game's sales than before. We believe that reaching the milestone of one million copies sold is an important milestone for the long-term potential of the Control brand, but also a financially very significant step in the company's transition to self-publishing. Control Resonant is now in an excellent position to sell with a long tail for several years.

We still believe our full-year sales estimate is at the right level, but our Q3 expectations were too front-loaded

We still believe that our current full-year sales estimate (1.9 million copies) is realistic. However, we will revise our assumptions regarding the timing of sales in connection with the Q3 preview. In retrospect, we had anticipated sales to be too front-loaded toward the end of September (the game was released on September 24), and our current Q3 forecast of 1.1 million copies is therefore too optimistic. This is also affected by the fact that when we made the forecast, we assumed that sales of physical copies would already be visible in the Q3 figures, whereas in reality, the physical copies only became available to players on October 15. Therefore, sales are more heavily weighted toward the last quarter of the year.

 

Login required

This content is only available for logged in users

Create account

Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.

Read more on company page

Key Estimate Figures28.09.

202526e27e
Revenue59.5125.2121.7
growth-%17.5 %110.4 %-2.8 %
EBIT (adj.)-14.95.015.0
EBIT-% (adj.)-25.0 %4.0 %12.3 %
EPS (adj.)-0.960.250.86
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.70.920.3
EV/EBITDA17.28.77.4

Forum discussions

I am completely aligned with Akee regarding the forecasts. Everything really needs to hit the mark for it to reach 1.9 million. It’s more likely...
1 hour ago
by Relaaja
1
1.9M for this year is totally doable. You’re underestimating holiday sales. A lot of digital gifts are bought, and physical copies will definitely...
1 hour ago
by Jarnis
6
Sell-in, of course. Anything else is just wishful thinking. One can take comfort in the fact that it likely surpassed ONE million in one fell...
1 hour ago
3
Or maybe these numbers include all physical sell-in? Who really knows, but we can throw around guesses, with or without AI. The positive tone...
2 hours ago
by Koli
4
That could be, but even then, they would verifiably have to be shipped/delivered to the customer. I wonder how many retailers report numbers...
2 hours ago
by Hasty
0
I would assume that all pre-ordered copies that were shipped when the physical version went on sale were counted as sales at that point, which...
2 hours ago
by Jarnis
2
It specifically says that it crossed the one million mark yesterday. Of course, you can’t tell from that whether yesterday’s physical sales ...
2 hours ago
10